Improved control of osteoarthritis pain and self-reported health status in non-responders to celecoxib switched to rofecoxib: results of PAVIA, an open-label post-marketing survey in Spain
Year: 2003
Type: article
Study design: Observational Study
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Merck Sharp and Dohme
OpenAlex ID: W2033053214
